Thursday, November 28, 2019
The Dream Theory Essay Example For Students
The Dream Theory Essay Dreams let your imagination flow, and my imagination sure does flow and produce some of the craziest dreams. When I recorded my dreams, there were a few common threads surrounded by family, friends (both old and current), as well as strangers who Iââ¬â¢ve never seen before or donââ¬â¢t recall ever seeing. Not only that but most of my dreams, overall, ended or began on a positive note. They also seemed to all relate to me in some way, whether it was due to the fact I pondered about those subjects sometimes, or because I was ââ¬Å"the main characterâ⬠or one of them anyway. We will write a custom essay on The Dream Theory specifically for you for only $16.38 $13.9/page Order now This self-centering was seen throughout all of my dreams I think about how global warming is going to affect the world in upcoming years, I was the only person talking at the store because I was paying for my friends and told them that they had to pay me back, Ben and I were doing the most of talking/play fighting, Harry and I were just talking about random things, and I became famous on youtube because some people decided to watch my DIY videos. Although my dreams sound pretty normal, most my dreams struck me as quite bizarre. Itââ¬â¢s not that I donââ¬â¢t have strange dreams at times, it was just that this time my imagination went sort over and beyond the normal amount resulting in strange places and events. For example, in my global warming dream, I dreamt that I was walking on a bridge that was in the middle of a body of water and there were waves that reached over 100 ft on either side of the bridge and never really crashed. Now call me weird for thinking that my dream was bizarre, but I know for a fact that a wave cannot randomly cease to exist in the middle and just stay at the same height without even the slightest drop or increase in height. Another really strange occurance in my dreams was when I payed for my friends stuff at a store and I told them to pay me back. This struck me as bizarre because my friends never even asked me to pay for them in the first place, and even were about to pay when I decided to step in and pay for them. The last strange incident was that I made DIY videos and put them on youtube, and actually became famous. I thought that this dream was weird because I always fail at my DIY projects and am frankly too lazy to upload videos onto youtube. My imagination was on overdrive during winter break. Although my dreams were quite bizarre, none of them disturbed me in a bad way but some had old friend which stirred up a bit of sadness, and one sort of made me want to better my actions. For example, in my dream about Ben, although it was a wonderful dream where Ben, I, Kirby, and Kyle were all hanging out and having fun, it made me feel somewhat put down. I wasnââ¬â¢t put down because we all had fun, but to be reminded that I am no longer closer to one of my closest friends since 4th grade because we simply grew apart. Unlike in my dream with Ben, my dream about global warming made me open my eyes in a different way. It didnââ¬â¢t cause sadness, but a sort of woke me up. I realized that global warming and its effects are taking a toll on us everyday, and that if we donââ¬â¢t something, even make the smallest effort to change, the effects could be detrimental. As in my dreams about my friend Ben, and global warming, I see a few common themes/symbols. One was that I always had familiar people around me, and all my dreams tended to be happy/casual for at least some part of the dream. I feel that always being surrounded by familiar people means that I like being with familiar people and am not an open and bubbly person who talks to everyone all the time. .u9e8e47d652f012efc28c871058c4399a , .u9e8e47d652f012efc28c871058c4399a .postImageUrl , .u9e8e47d652f012efc28c871058c4399a .centered-text-area { min-height: 80px; position: relative; } .u9e8e47d652f012efc28c871058c4399a , .u9e8e47d652f012efc28c871058c4399a:hover , .u9e8e47d652f012efc28c871058c4399a:visited , .u9e8e47d652f012efc28c871058c4399a:active { border:0!important; } .u9e8e47d652f012efc28c871058c4399a .clearfix:after { content: ""; display: table; clear: both; } .u9e8e47d652f012efc28c871058c4399a { display: block; transition: background-color 250ms; webkit-transition: background-color 250ms; width: 100%; opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; background-color: #95A5A6; } .u9e8e47d652f012efc28c871058c4399a:active , .u9e8e47d652f012efc28c871058c4399a:hover { opacity: 1; transition: opacity 250ms; webkit-transition: opacity 250ms; background-color: #2C3E50; } .u9e8e47d652f012efc28c871058c4399a .centered-text-area { width: 100%; position: relative ; } .u9e8e47d652f012efc28c871058c4399a .ctaText { border-bottom: 0 solid #fff; color: #2980B9; font-size: 16px; font-weight: bold; margin: 0; padding: 0; text-decoration: underline; } .u9e8e47d652f012efc28c871058c4399a .postTitle { color: #FFFFFF; font-size: 16px; font-weight: 600; margin: 0; padding: 0; width: 100%; } .u9e8e47d652f012efc28c871058c4399a .ctaButton { background-color: #7F8C8D!important; color: #2980B9; border: none; border-radius: 3px; box-shadow: none; font-size: 14px; font-weight: bold; line-height: 26px; moz-border-radius: 3px; text-align: center; text-decoration: none; text-shadow: none; width: 80px; min-height: 80px; background: url(https://artscolumbia.org/wp-content/plugins/intelly-related-posts/assets/images/simple-arrow.png)no-repeat; position: absolute; right: 0; top: 0; } .u9e8e47d652f012efc28c871058c4399a:hover .ctaButton { background-color: #34495E!important; } .u9e8e47d652f012efc28c871058c4399a .centered-text { display: table; height: 80px; padding-left : 18px; top: 0; } .u9e8e47d652f012efc28c871058c4399a .u9e8e47d652f012efc28c871058c4399a-content { display: table-cell; margin: 0; padding: 0; padding-right: 108px; position: relative; vertical-align: middle; width: 100%; } .u9e8e47d652f012efc28c871058c4399a:after { content: ""; display: block; clear: both; } READ: A Different World EssayIn addition, I feel the common theme of happiness and casualness means that I tend to put aside stressors and concentrate on the good rather than the bad, and that I like to be laid back and relaxed. In this way I feel that my dreams are very relevant to my waking life because I donââ¬â¢t usually tend to talk to new people, and I do love relaxing and hanging out with people I am familiar with. All together my dreams seem to have one main function to get me ready to face any obstacle and not be afraid when I am faced with something new. The manifest content of all my dreams was being happy and having a good time, other than my global warming dream which was to wake up and see what is happening around me at a fairly rapid pace. The latent content, however, differed slightly from dream to dream. My dream about global warming was telling me to do something to lessen the amount that I contribute to global warming, while my dream about paying for my friends reminded me that I forgot that they actually had to pay me back money from previous time (and at those times they actually asked to borrow money from me). My dream about my old friend told me to remember the bittersweet friendship but not latch on to the memories and keep hoping that weââ¬â¢ll be friends again, while my dream about talking to Harry in Med Tech about random things showed me that we lose friends but then we gain others, and my dream about becoming famous told me that I really want to become famous and to also succeed at finishing DIY projects correctly.
Sunday, November 24, 2019
The Man who makes History essays
The Man who makes History essays The believe that it is the man who determines history is totally true. The man is the cause of almost anything is great regard in history. The actions of man has been to go against what is perceived as impossible. To defy the odds and go against the grain. Jesse Owens and Muhammad Ali, prove the position at hand. In Jesse Owens case, you could say that he was in the right place at the right time. However, he was an American. An African-American. An African-American who was going against, the Master Race of Adolf Hitler. Not to mention the hostile crowd that packed the Coliseum of Berlin in the 1936 Olympics. Owens went on to win 4 gold medals, in the 100 meters, 200 meters, the long jump, and the 4x100 relay. If it were any other American, this event wouldnt have so much. Since it was Mr. Owens, it meant that much more. You would expect a boxer who is brash, cocky, and who had a swagger one could only dream, to be hated by everyone. To have the living daylights knocked out of them by someone who didnt want to hear about all the crap he had been saying days before a fight. For Cassius Clay, also known as Muhammad Ali, Ali was confident, not arrogant. Ali believed, he didnt fill the hype. He just believed in what he knew and he let everyone know about it. When the Vietnam war arouse in the late 1960s, Muhammad Ali was given a forced decision. He received a letter in the mail telling him by the Selective Service that he must report to camp to prepare to go to Vietnam for war. He had one of two choices, number #1, to go to war and not go to jail even though his Muslim belief stated that it was wrong, or number #2, go to jail, give up his Heavyweight championship, and go in opposition to the government, and stick up for what he believed in. So he went to jail, lost his title, and stood up for wh at he believed in, all is it in the prime of his ...
Thursday, November 21, 2019
Que Onda Urban Youth Culture and Border Identity Essay - 4
Que Onda Urban Youth Culture and Border Identity - Essay Example stigation of the Mexican cultural traits, the work demonstrates the brilliance and command of the author over human thoughts and psychology on the one side, and activities and interests the individuals belonging to various ethno-racial groups observe on the other. Thus, Bejarano has skillfully elaborated the problems faced by various ethno-racial communities in respect of their identities and traditions while living in a multi-cultural country and interacting the people belonging to many cultural and social groups. The Mexican youth, according to Bejarano (2007 4), represents the distinguished historical heritage attributed to their traditional civilization. The author views schools and educational institutions to be one of the most astounding reflections of the culture as well as the developments being made within a social structure (4-5). It is particularly the case with the immigrant ethno-racial groups, which make an impressive presentation of the cultural background as well as the social positioning they belong to. The minority racial and ethnic groups, according to the author, adopt several things from the mainstream culture through assimilation and interaction with others. However, an imperative majority of them do not give up the customs and values have been attributed to their forefathers. It is equally the case with the Latinos, Mexicans, Indians, African Americans and Asians at large. It is therefore the age-old minority groups residing in the USA for the last many decades share var ious traits with the newly migrated minority groups belonging to their race and ethnicity (Wilson & Gutierrez 1995 2). It is partly because of the influx of immigrants to the USA by the last decade of twentieth century, where the US administrations supported and promoted immigration in order to invite the brilliant and educated individuals to their country from all corners of the globe at large (Bejarano 23). Modern US historian Marcus Hansen has articulated his principle of
Wednesday, November 20, 2019
Overview and Advertisement related to Social Networking Essay
Overview and Advertisement related to Social Networking - Essay Example There were times when people had very less friends, they used to socialize very less, there were very less options a person could consult with or people had to go to professional consultants for advise, they had to spend a large some of money for data they required. People used to have very less material for entertainment and people found or referred there life as boring due to less activities and social life, that part of time was when there was no social soft wares or very less soft wares with very limited options in it like MSN and Yahoo messenger which allowed itââ¬â¢s users to interact with different people by finding there email identities and adding them in their messenger software to interact or share different utilities, but this was limited only from one to one user until soft wares like Face book came into being. Nowadays in the modern world the rise of different communication setups can be witnessed. Many things can be included in these communication setups such as Msn Messenger Yahoo Messenger and other similar services. Similarly with the advent of new technologies it is witnessed that social communication through websites is on the rise. Social Communication websties such as Facebook and Myspace are real life examples of such a service. Facebook and Myspace which were originally developed to serve a single community have now been expanded all over the world. Both of these entitites started off with college students and they have now turned out to be world changing entitites.
Monday, November 18, 2019
Evaluate the training Essay Example | Topics and Well Written Essays - 500 words
Evaluate the training - Essay Example iduals to provide better customer services, there are some sound principles that the evaluation process must be based upon and some four levels of evaluation that need be considered. Sometimes trainers fail to address the importance of having the evaluation process fit the specific standards and levels of training. Drawing generalizations from a single evaluation design fails to identify the strengths and weaknesses of training given there are different objectives. Level one- results/impacts: this level measures the effectiveness of the evaluation initiative. While this level is the most difficult to consume while compared to the other three, it is evidently the most important as it underscores the whole process. Measurement of results of the learning process might be looked at in the following perspectives: Level three, on the other hand, looks at leaning in the extent to which the learners were able to improve their knowledge and skills and where they also had a change in attitudes after going through the learning process. The last levels measure how the learner perceives and maybe react to both the learning and performance process. The level, known as motivation, makes use of attitude questionnaires passed out after the completion of the learning
Friday, November 15, 2019
Accelerated Pathways for Authorisation of Drugs
Accelerated Pathways for Authorisation of Drugs Mary Treasa Lohan Abstract and Summary Every year, thousands of chemical and biological entities are developed in the hope of making it to the shelf. The drug development process is the progression by which drugs will either be approved or not approved for use, and spans from discovery and preclinical testing to Phase IV of Clinical Trials (post marketing surveillance). The underpinning aim is to ensure the safety and efficacy of a drug before it can be approved for use. Given that only one in every 5,000 to 10,000 compounds that enter preclinical testing are approved for marketing, and that an average of 15 years is required to take a drug through the complete process, the drug development process is a long and costly one. The two main regulatory bodies in the world are the FDA (USA) and the EMA (EU) and while the drug approval process varies from the EU to the USA, the basic regulation process remains the same. Figure 1 Basic drug development regulation à à (Kashyap et al., 2013) 1.1. Drug approval process in the US In brief, the process of drug approval in the US first involves the submission of an Investigational New Drug application by the Sponsor. This allows the Clinical Trials to commence once the data from the Preclinical trials shows that the drug is safe. Once the drug is shown to be safe and effective (Clinical Trials data), a New Drug Application is filed which is essentially an application to manufacture and sell the drug (Rick, 2009). 1.1. Drug approval process in the EU The application process for the EU, similar to the US, requires two steps. The first step is a clinical trial application to an individual member state, and then a marketing approval. The marketing approval in the EU can take one of three approaches The centralised procedure The mutual recognition procedure The decentralised procedure As mentioned before, the purpose of the drug development process is to ensure safe and effective drugs are available to the patient. However, both the US and EU processes are very lengthy procedures and often do not provide rapid patient access to drugs. There is of course a balance to be struck between providing patients with rapid access to medicines and ensuring adequate information is available regarding the risk-benefit factors of the drug, sometimes termed the evidence versus access challenge (Eichler et al., 2015). 1.2. Improvements In recent times however, much has been done to try and improve the situation (Baird et al., 2014). In the EU, there are two means to fast track approval of a drug; Accelerated assessment and Conditional marketing authorisation. The Conditional marketing authorisation process allows the approval of a medicine that address unmet medical needs of patients on the basis of less comprehensive data than normally required. The available data must indicate that the medicines benefits outweigh its risks and the applicant should be in a position to provide the comprehensive clinical data in the future (EMA, 2015). In 2014, the EMA initiated a pilot project for a new model of drug testing and marketing called Adaptive Pathways (also known as Adaptive Licensing, or more recently the terms Medicines Adaptive Pathways (MAPs) or Medicines Adaptive Pathways to Patients (MAPPs) have been used). This concept allows new drugs that would treat unmet medical needs to be launched on the market faster, based on an incomplete data set (Davis et al., 2016). This project aims to discuss Adaptive Pathways in general, the different types of Adaptive Pathways, as well as the types of drugs that are suitable for these pathways. Finally, the Adaptive Pathway approval strategies in the EU and the US will be discussed. 2.1. Adaptive Pathways 2014 saw the introduction of a pilot program by which drugs could potential to make it to the market faster in order to fulfil unmet medical needs, the Adaptive Pathway. The idea was to ensure timely patient access to new drugs, while ensuring adequate risk benefit information was available. The Adaptive Pathways model presented by the EMA is not a new route of marketing authorisation but rather makes use of existing regulatory approaches such as the conditional marketing authorisation or the standard marketing authorisation. Using this pilot program, drugs could be authorized conditionally or in a staggered fashion using data gathered throughout the life of the product. The three key principles of Adaptive Pathways are; Iterative development Gathering real-life evidence Early involvement of stakeholders Bearing in mind that drugs are approved through adaptive pathways based on incomplete data and are given market approval earlier in the development process, iterative development refers to the gathering of data to increase knowledge after authorisation. It is a staggered approach to widen the target population or expand the indication. The data collected can also be used to reduce any uncertainties that were present at the early approval stage. A key component of Adaptive Pathways is a well-defined prospective plan for collecting real-life data that can be used in conjunction with the Clinical Trials data to enhance the risk benefit ratio (Eichler et al., 2012). Communication between stakeholders is critical and helps to decide what medicines are suitable, and are also responsible for creating an agreed prospective plan required for data gathering throughout the lifecycle of the product. Stakeholders are involved from a very early stage and can include health technology assessment (HTA) bodies, patients, as well as regulators and healthcare professionals. 2.2. Benefits and challenges of Adaptive Pathways The obvious advantage of the Adaptive Pathway is that the patient can potentially have access to a drug in a much shorter time period than if the drug had to go through the standard application process. If the drug shows a good risk benefit outcome, the drug can be approved at an earlier stage, while real-life data is gathered at predefined intervals from patients to confirm effectiveness. There is also the opportunity for drugs to be fully approved within a shorter timeframe than normal.Ãâà Eichler also suggests that this process may reduce the overall cost of development by allowing better-informed decisions on product viability to be made earlier in the development process (Eichler et al., 2012). Eichler has published an article detailing the enablers of this new concept (Eichler et al., 2015). However, since the publication of the EMAs final report in July following the completion of the pilot program, a number of articles have been published which criticise the new concept (Eichler et al., 2012) (Woodcock, 2012). Unlike the standard authorisation, the Adaptive Pathway uses preliminary data and omits a number of steps that were designed to protect patients from unsafe and ineffective drugs and, this raises concerns as to whether this can potentially lead to increased risk to the patient. For adaptive Pathways to work, it is critical that evidence obtained after initial approval be taken into consideration. However, it has been found that healthcare professionals are often slow to abandon unsafe methods (Tatsioni et al., 2007). This is worrying as the basis of Adaptive Pathways is that reliable data is generated after authorisation that will shed more light on the risk benefit to the patient. Another serious concern relates to the life cycle management of the new drug (Davis et al., 2016). As mentioned earlier, a key principle of the Adaptive Pathway is gathering real-life evidence in post-marketing studies that would be used to update the risk benefit information. However, it would seem that in the case of conditionally approved drugs, the regulatory bodies have failed to ensure post-marketing study commitments are followed through (Banzi et al., 2015). It has also been suggested that where undesirable findings are encountered, companies may dispute these as unreliable results (McCabe et al., 2010) or may discount them because there are large financial gains or reputations at risk (Prasad et al., 2012). Moreover, the willingness of stakeholders to participate in a program that involves more uncertainty, and correspondingly perhaps more risk, than before will be one of the greatest challenges to the Adaptive Pathway. 2.3. Suitable drugs for Adaptive Pathways The report issued by the EMA suggests that drugs that treat infectious diseases, Alzheimers disease, degenerative diseases and rare cancers are potential candidates for this process with the objective of furthering their development and that suitable for the Adaptive Pathways would be those that treat rare diseases, where clinical data is not that common. The EMA have provided a flowchart to help companies determine if a product is an appropriate candidate or not, (Figure 2). Based on this, the key features of a drug that could be deemed suitable for this Adaptive Pathways approach are; iterative development, collaboration with HTA, and the use of real time data for regulatory purposes. Figure 2 Adaptive Pathway product eligibility flowchart While there is no strict restriction on what type of drugs are eligible for the Adaptive Pathways, the EMA states that this route is not to be applicable to all medicines, but only to medicines that are likely to address an unmet medical need(EMA, 2016). During the pilot, 62 applications were received from a variety of therapeutic areas with cancer therapies accounting for a large proportion (33%). It is worth noting that Orphan designated drugs are suitable candidates, with 5 making it through to Stage 1 Meetings (15 drugs had been given Orphan drug designation by the European Commission at the time of submission) (EMA, 2016). (EMA, 2016) 2.5. Adaptive Pathway approval strategy in the USA Within the USA, there are four approaches to getting drugs on the market as rapidly as possible, and in each case the drug must be intended to treat a serious condition. A serious condition is defined as a disease or condition associated with morbidity that has a substantial impact on day-to-day functioning Fast Track Breakthrough Therapy Accelerated Approval Priority Review Fast Track refers to the process, approved in 1992 under the Prescription Drug User Fee Act, by which drugs needed to treat serious conditions or to fulfil unmet medical needs are rapidly approved. According to the FDA, filling an unmet medical need is defined as providing a therapy where none exists or providing a therapy which may be potentially better than available therapy (FDA, 2014). This strategy means more communication with the FDA regarding the drug development plan, data collection and clinical trials design. In addition, a Fast Track designated drug is potentially eligible for Accelerated Approval and Priority Review if it meets the applicable criteria. Breakthrough Therapy designation accelerates the development of drugs needed to treat serious conditions that have shown substantial advantages over existing treatments in early clinical studies (Poirier and Murphy, 2016). This strategy utilises a surrogate endpoint. A surrogate endpoint is a marker used to determine effectiveness of a drug, such as the shrinking of a tumour and is often used rather than actual clinical endpoints, such as survival rates. Another example would be a significantly improved safety profile compared to available therapy (FDA). In addition to the Fast Track designation benefits, Breakthrough Therapy drugs receive a vast amount of guidance with the drug development program. Referencesà BAIRD, L. G., BANKEN, R., EICHLER, H. G., KRISTENSEN, F. B., LEE, D. K., LIM, J. C. W., LIM, R., LONGSON, C., PEZALLA, E. SALMONSON, T. 2014. Accelerated access to innovative medicines for patients in need. Clinical Pharmacology Therapeutics, 96, 559-571. BANZI, R., GERARDI, C. GARATTINI, S. 2015. Approvals of drugs with uncertain benefit-risk profiles in Europe. European journal of internal medicine, 26, 572-584. DAVIS, C., LEXCHIN, J., JEFFERSON, T., GÃËTZSCHE, P. MCKEE, M. 2016. Adaptive pathways to drug authorisation: adapting to industry? BMJ: British Medical Journal, 354. EICHLER, H. G., BAIRD, L. G., BARKER, R., BLOECHLà ¢Ã¢â ¬Ã DAUM, B., BÃËRLUMà ¢Ã¢â ¬Ã KRISTENSEN, F., BROWN, J., CHUA, R., DEL SIGNORE, S., DUGAN, U. FERGUSON, J. 2015. From adaptive licensing to adaptive pathways: Delivering a flexible lifeà ¢Ã¢â ¬Ã span approach to bring new drugs to patients. Clinical Pharmacology Therapeutics, 97, 234-246. EICHLER, H. G., OYE, K., BAIRD, L. G., ABADIE, E., BROWN, J., L DRUM, C., FERGUSON, J., GARNER, S., HONIG, P. HUKKELHOVEN, M. 2012. Adaptive licensing: taking the next step in the evolution of drug approval. Clinical pharmacology and therapeutics, 91, 426. EMA. 2015. Fast track routes for medicines that address unmet medical needs [Online].Ãâà [Accessed]. EMA 2016. Final report on the adaptive pathways pilot. FDA. Breakthrough Therapy [Online]. Available: http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm [Accessed]. FDA. 2014. Fast Track [Online]. Available: http://www.fda.gov/ForPatients/Approvals/Fast/ucm405399.htm [Accessed]. KASHYAP, U. N., GUPTA, V. RAGHUNANDAN, H. V. 2013. Comparison of Drug Approval Process in United States & Europe. J Pharm Sci Res, 5, 131-6. MCCABE, C., CHILCOTT, J., CLAXTON, K., TAPPENDEN, P., COOPER, C., ROBERTS, J., COOPER, N. ABRAMS, K. 2010. Continuing the multiple sclerosis risk sharing scheme is unjustified. Bmj, 340, c1786. POIRIER, A. F. MURPHY, W. R. 2016. The Impact of Breakthrough Therapy Designation on Development Strategies and Timelines for Nononcology Drugs and Vaccines. Clinical Pharmacology Therapeutics, 100, 603-605. PRASAD, V., CIFU, A. IOANNIDIS, J. P. A. 2012. Reversals of established medical practices: evidence to abandon ship. Jama, 307, 37-38. RICK, N. 2009. Drugs from discovery to approval., John Wiley & Sons, Inc. TATSIONI, A., BONITSIS, N. G. IOANNIDIS, J. P. A. 2007. Persistence of contradicted claims in the literature. Jama, 298, 2517-2526. WOODCOCK, J. 2012. Evidence vs. Access: Can Twentyà ¢Ã¢â ¬Ã Firstà ¢Ã¢â ¬Ã Century Drug Regulation Refine the Tradeoffs? Clinical Pharmacology Therapeutics, 91, 378-380. staggered or conditional marketing authorization AL is expected to involve a trade-off between earlier access for some patients vs. an increased level of acceptable uncertainty about benefits and risks, although the degree of uncertainty is expected to diminish with additional evidence generation. One of the main purposes of the AL scheme is to get more robust and more relevant data earlier and throughout product development. Any attempt to move toward a more adaptive approach would have to be complemented by appropriate communications to key stakeholders and assurance that the appropriate post-initial authorization capabilities exist for ongoing monitoring of medical products for which AL has been applied
Wednesday, November 13, 2019
In Defense of Capital Punishment :: Pro Capital Punishment Essays
In Defense of Capital Punishment There are some words that often return when we defend the death penalty: justice and human dignity. These words also constitute a foundation for that which is called democracy and civilization. These two realities can also be regarded as two bearing pillars in the defense of capital punishment. Justice is a highly regarded word in society and in politics, but within the judicial system and that which concerns crime and punishment, justice has, both as a word and as a conception, ended up existing in the shadows. People want to lift forth this truth in the light, since justice should be the foundation within the legal system. When the death penalty is discussed the aspect of justice should be allowed in the foreground first and foremost. Man has an inviolable dignity and, therefore, deserves the highest respect. Human dignity and respect, not foremost for the one who hurts his fellowman but for the victims of crimes and his relatives, is something that should be brought forth considerably more than today, and especially in connection with the death penalty. But the prerequisite for that is that sympathy and solidarity with the victim should increase in society. In order to rightly value the death penalty it is necessary to have empathy and understanding for all the victims and their relatives. The capital punishment makes up one link on the way to a safer society. The capital punishment means that some heinous criminals never again will walk on the streets, and that makes the society a somewhat safer place. Murderers and violent criminals will always exist in society and the death penalty will only lower the number of criminals marginally. It is inevitable, however, that every violent criminal less that exists in a society will mean a safer society. A prison term on the other hand would mean that there would always be a pressing dark cloud of worries over a society. Also, in prisons the interns and personnel would feel safer with the death penalty. It is not unusual with conflicts, violence and murder in prison. Some interns who have been sentenced to long prison terms or lifetime would probably deter from cruel acts of violence and murder if they knew that it could lead to the death penalty. Today, on the other hand, he who has been sentenced to lifetime in prison cannot be sentenced too much more and, therefore, he would probably neither be deterred from committing further crimes. In Defense of Capital Punishment :: Pro Capital Punishment Essays In Defense of Capital Punishment There are some words that often return when we defend the death penalty: justice and human dignity. These words also constitute a foundation for that which is called democracy and civilization. These two realities can also be regarded as two bearing pillars in the defense of capital punishment. Justice is a highly regarded word in society and in politics, but within the judicial system and that which concerns crime and punishment, justice has, both as a word and as a conception, ended up existing in the shadows. People want to lift forth this truth in the light, since justice should be the foundation within the legal system. When the death penalty is discussed the aspect of justice should be allowed in the foreground first and foremost. Man has an inviolable dignity and, therefore, deserves the highest respect. Human dignity and respect, not foremost for the one who hurts his fellowman but for the victims of crimes and his relatives, is something that should be brought forth considerably more than today, and especially in connection with the death penalty. But the prerequisite for that is that sympathy and solidarity with the victim should increase in society. In order to rightly value the death penalty it is necessary to have empathy and understanding for all the victims and their relatives. The capital punishment makes up one link on the way to a safer society. The capital punishment means that some heinous criminals never again will walk on the streets, and that makes the society a somewhat safer place. Murderers and violent criminals will always exist in society and the death penalty will only lower the number of criminals marginally. It is inevitable, however, that every violent criminal less that exists in a society will mean a safer society. A prison term on the other hand would mean that there would always be a pressing dark cloud of worries over a society. Also, in prisons the interns and personnel would feel safer with the death penalty. It is not unusual with conflicts, violence and murder in prison. Some interns who have been sentenced to long prison terms or lifetime would probably deter from cruel acts of violence and murder if they knew that it could lead to the death penalty. Today, on the other hand, he who has been sentenced to lifetime in prison cannot be sentenced too much more and, therefore, he would probably neither be deterred from committing further crimes.
Subscribe to:
Comments (Atom)